Drugs

Scientific Rationale for Combination of a Calcium Channel Antagonist and an HMG-CoA Reductase Inhibitor: A New Approach to Risk Factor Management
pp. 885-900(16)
Author: Mason, R. Preston

Novel Thrombopoietic Agents: A Review of Their Use in Idiopathic Thrombocytopenic Purpura
pp. 901-912(12)
Authors: Stasi, Roberto; Evangelista, Maria L.; Amadori, Sergio

Management of Breakthrough Pain in Patients with Cancer
pp. 913-924(12)
Authors: William, Leeroy; MacLeod, Rod

Guide to the Use of Proton Pump Inhibitors in Adult Patients
pp. 925-947(23)
Authors: Boparai, Vandana; Rajagopalan, Jaishree; Triadafilopoulos, George

Capecitabine, Alone and in Combination, in the Management of Patients with Colorectal Cancer: A Review of the Evidence
pp. 949-961(13)
Authors: Comella, Pasquale; Casaretti, Rossana; Sandomenico, Claudia; Avallone, Antonio; Franco, Luca

Renal Disease in Patients with HIV Infection: Epidemiology, Pathogenesis and Management
pp. 963-980(18)
Authors: Fine, Derek M.; Perazella, Mark A.; Lucas, Gregory M.; Atta, Mohamed G.

Mosapride: In Gastrointestinal Disorders
pp. 981-991(11)
Authors: Curran, Monique P.; Robinson, Dean M.

Posaconazole: A Review of its Use in the Prophylaxis of Invasive Fungal Infections
pp. 993-1016(24)
Authors: Frampton, James E.; Scott, Lesley J.

Drugs in the Newspapers
pp. 1017-1018(2)
Authors: Velo, Giampaolo; Renzi, Riccardo; Satolli, Roberto